Approval · Notice of Compliance 22251 · 2019
ONPATTRO: Notice of Compliance 22251
Issued June 7, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22251
- Date
- June 7, 2019
- Company
- Alnylam Netherlands B.V.Amsterdam, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONPATTRO | 02489252 | Marketed |
Medicinal ingredients
- PATISIRAN SODIUM 2 MG per ML